We are delighted to announce that George Siber, President of Siber Biotechnologies LLC, will be speaking at VIF World 2025. Dr. Siber, a veteran in the vaccine industry, will share his insights on ...
VIF World 2025 is honored to host Emanuel Montomoli, Professor of Public Health at the University of Siena and CSO of VisMederi. Professor Montomoli will discuss the critical role of immunogenicity...
Dr. Jicui Dong, Unit Head of the Local Production & Assistance Unit at the World Health Organization, will be a key speaker at VIF World 2025. Dr. Dong will provide insights into WHO’s strategies f...
We are pleased to announce that Simon Graham, Professor at The Pirbright Institute, will be speaking at VIF World 2025. Professor Graham is renowned for his research in vaccine immunology, particul...
Mahesh Kumar, Senior Vice President of R&D at Zoetis, will share his expertise at VIF World 2025. With a focus on biologics and animal vaccines, Mr. Kumar will discuss the latest advancements in ve...
Hun Kim, President of Global Business at SK bioscience, will join VIF World 2025 as a distinguished speaker. Mr. Kim has played a pivotal role in expanding South Korea’s vaccine industry on a globa...
VIF World 2025 is proud to welcome Raches Ella, Chief Development Officer at Bharat Biotech, as a speaker. Mr. Ella has been instrumental in advancing several key vaccine projects, including those ...
We are excited to announce that Rajinder Suri, CEO of DCVMN International, will be a featured speaker at VIF World 2025. With his extensive experience in strengthening vaccine manufacturing capacit...
Nov. 9, 2023——The U.S. Food and Drug Administration (FDA) has given the green light to Ixchiq, the world's first chikungunya vaccine developed by Velneva, an Austrian biotech. This vaccine is now a...
In a remarkable stride towards global health, Bio Farma's Bio-TCV® typhoid conjugate vaccine (TCV) has received licensing in Indonesia, following marketing approval from the national regulatory aut...
